2022 Movember-PCF VAlor Challenge Award
The Rate Elements Skewing Outcomes Linked to Veteran Equity in PCa (RESOLVE PCa) Consortium: Multilevel Modeling to Predict Prostate Cancer Incidence and Aggressiveness
Principal Investigators: Isla Garraway, MD, PhD (University of California, Los Angeles; Greater Los Angeles VA Healthcare System), Kara Maxwell, MD, PhD (University of Pennsylvania), Corporal Michael J. Crescenz VA Medical Center), Kosj Yamoah, MD, PhD (Moffit Cancer Center), Timothy Rebbeck, PhD (Dana-Farber Cancer Institute; Harvard TH Chan School of Public Health), Brent Rose, MD (University of California, San Diego)
Co-Investigators: Daniel Lee, MD, MS (University of Pennsylvania), Nicholas Nickols, MD, PhD (University of California, Los Angeles), Michael Lewis, MD (Greater Los Angeles VA Healthcare System), Matthew Rettig, MD (University of California, Los Angeles), Saiju Pyarajan, PhD (Brigham and Women’s Hospital)
2022 Movember-Distinguished Gentleman’s Ride-PCF VAlor Challenge Award
IRONMAN: Enhancing Survivorship in Patients with Advanced Prostate Cancer
Principal Investigators: Lorelei Mucci, ScD, MPH (Harvard T.H. Chan School of Public Health), Daniel George, MD (Duke University)
Co-Investigators: Dana Rathkopf, MD (Memorial Sloan Kettering Cancer Center), Konrad Stopsack, MD, MPH (Harvard T.H. Chan School of Public Health), Terry Hyslop, PhD (Duke University), Karen Autio, MD (Memorial Sloan Kettering Cancer Center), Deborah Enting, MD, PhD (Guy’s and St Thomas’ NHS Foundation Trust)
Young Investigators: Yiwen Zhang, PhD (Harvard T.H. Chan School of Public Health), Hannah McManus, MD (Duke University)
2022 Michael & Lori Milken Family Foundation-PCF Challenge Award
Mechanisms of Response and Resistance to DLL3-Targeted T Cell Engager Therapy
Principal Investigators: Himisha Beltran, MD (Dana-Farber Cancer Institute)
Co-Investigators: Andres Acosta, MD (Brigham and Women’s Hospital), Jacob Sands, MD (Dana Farber Cancer Institute), Sheng-Yu Ku, PhD (Dana-Farber Cancer Institute)
2022 Stewart Rahr Foundation-PCF Challenge Award
Hormonal Shock Therapy for Metastatic Castrate Resistant Prostate Cancer
Principal Investigators: Samuel Denmeade, MD (Johns Hopkins University), Robert Casero, PhD (Johns Hopkins University), Erika Pearce, PhD (Johns Hopkins University)
Co-Investigators: Laura Sena, MD, PhD (Johns Hopkins University), Angelo DeMarzo, MD (Johns Hopkins University), Hao Wang, PhD (Johns Hopkins University), David Sanin, PhD (Johns Hopkins University)
2022 John Black Charitable Foundation-PCF Challenge Award
First-In-Man PARP1-Selective Inhibitor in Lethal Prostate Cancer: Mechanisms of Action and Biomarkers of Therapeutic Response
Principal Investigators: Harveer Dev, MD, PhD (University of Cambridge), Simon Pacey, MD, PhD (University of Cambridge), Charlie Massie, PhD (University of Cambridge)
Co-Investigators: Hisham Mohammed, PhD (Knight Cancer Institute)